TY  - CHAP
AU  - Teresa de Souza Fernandez
AU  - André Mencalha
AU  - Cecília de Souza Fernandez
ED  - Tapan Kumar Khan
Y1  - 2012-04-27
PY  - 2012
T1  - Epigenetics in Cancer: The Myelodysplastic Syndrome as a Model to Study Epigenetic Alterations as Diagnostic and Prognostic Biomarkers
N2  - Clinicians, scientists, and health care professionals use biomarkers or biological markers as a measure of a person’s present health condition or response to interventions. An ideal -biomarker should have the following criteria: (I) ability to detect fundamental features of the disease, (II) ability to differentiate from other closely related diseases, (III) ability to detect early stages and stages of progression, (IV) the method should be highly reliable, easy to perform and inexpensive, and (V) sample sources should be easily accessible from body. Most of the chapters in this book follow the basic principle of biomarkers.
BT  - Biomarker
SP  - Ch. 2
UR  - https://doi.org/10.5772/38754
DO  - 10.5772/38754
SN  - 
PB  - IntechOpen
CY  - Rijeka
Y2  - 2024-04-26
ER  -